Short pages
Jump to navigation
Jump to search
Showing below up to 50 results in range #20,321 to #20,370.
- (hist) Di-tert-butyl ether [412 bytes]
- (hist) Adcon-L [412 bytes]
- (hist) ME Association [412 bytes]
- (hist) National AIDS Control Programme [412 bytes]
- (hist) Eros (Freud) [412 bytes]
- (hist) Spirochaetaceae [412 bytes]
- (hist) Borders General Hospital [412 bytes]
- (hist) Compliance [412 bytes]
- (hist) Coronary artery bypass surgery videos [412 bytes]
- (hist) Essential thrombocytosis primary prevention [412 bytes]
- (hist) Hamartoma cost-effectiveness of therapy [412 bytes]
- (hist) Hamartoma future or investigational therapies [412 bytes]
- (hist) Mucoepidermoid carcinoma primary prevention [412 bytes]
- (hist) Myelofibrosis secondary prevention [412 bytes]
- (hist) MALT lymphoma cost-effectiveness of therapy [412 bytes]
- (hist) MALT lymphoma future or investigational therapies [412 bytes]
- (hist) Acute brachial neuritis diagnosis [412 bytes]
- (hist) Meningococcemia case study one [412 bytes]
- (hist) Meningococcemia surgery [412 bytes]
- (hist) Umbilical hernia classification [412 bytes]
- (hist) Melena CT [412 bytes]
- (hist) Transitional cell carcinoma other diagnostic studies [412 bytes]
- (hist) MALT lymphoma case study one [412 bytes]
- (hist) Hamartoma case study one [412 bytes]
- (hist) Androgen insensitivity syndrome case study one [412 bytes]
- (hist) Hypernatremia case study one [412 bytes]
- (hist) Macrocytic anemia screening [412 bytes]
- (hist) Respiratory failure case study one [412 bytes]
- (hist) Candida vulvovaginitis other diagnostic studies [412 bytes]
- (hist) Pneumonic plague classification [412 bytes]
- (hist) Shock historical perspective [412 bytes]
- (hist) Shock differential diagnosis [412 bytes]
- (hist) Shock epidemiology and demographics [412 bytes]
- (hist) Shock risk factors [412 bytes]
- (hist) Shock screening [412 bytes]
- (hist) Shock history and symptoms [412 bytes]
- (hist) Shock CT [412 bytes]
- (hist) Shock MRI [412 bytes]
- (hist) Shock other imaging findings [412 bytes]
- (hist) Shock surgery [412 bytes]
- (hist) Shock primary prevention [412 bytes]
- (hist) Shock secondary prevention [412 bytes]
- (hist) Shock cost-effectiveness of therapy [412 bytes]
- (hist) Shock future or investigational therapies [412 bytes]
- (hist) Shock case study one [412 bytes]
- (hist) Laryngomalacia endoscopy [412 bytes]
- (hist) Epiglottitis screening [412 bytes]
- (hist) Breast abscess CT [412 bytes]
- (hist) TMEM215 [412 bytes]
- (hist) ARL13A [412 bytes]